How to earn points and gain rank? Sell in May, Buy gamma scalping forex trading October : it works! USDJPY 3candles and reversal strategy with ADX and VOL filter.
Winning when the market declines ! Access to this page has been denied because we believe you are using automation tools to browse the website. United Kingdom with an interest in technology stocks. A third George Ronan, with no bio but a decidedly different headshot, was briefly among the contributors to Benzinga. The purported analysis pieces by the multiple George Ronans are a prime example. Sharesleuth turned up more than 140 articles with that byline, on seven different sites.
Most of the original Ronan’s 11 articles at Seeking Alpha called attention to companies that were created or bankrolled by Barry C. Honig, a South Florida financier who figures into at least two Securities and Exchange Commission investigations. So did six of the seven Ronan articles on four other sites, including Investing. Using the Ronan stories as markers, we found more than 60 other writers who have systematically promoted companies connected to Honig and his associates, including longtime business partner Michael H.
Phillip Frost, chairman and chief executive of Opko Health Inc. Sharesleuth determined that the majority of those writers also were fake — part of an elaborate, long-running effort to spark interest in obscure public companies by creating bullish stories that were posted and reposted across the internet. The stealth promotion network includes a handful of real people who have touted the same stocks with such regularity that it is impossible to view their posts as a coincidence. All told, we turned up nearly 600 bullish articles about Honig-related companies that fit the pattern of stealth promotional pieces. Nearly 50 stories posted on Gurufocus. More than 40 stories posted on Trefis.
More than 20 stories posted at Investing. They also appeared in news summaries for the featured companies at Nasdaq. That’s the exchange where most of those stocks trade. We have been watching for more than a year, to determine how the articles originate, how the campaigns spread and how they help to boost share prices and trading volumes. Among other things, we found concentrations of stories in the days and weeks leading up to share sales, and just before and after mergers, acquisitions or other market-moving events. We discovered nearly 40 instances where writers in the stealth promotion network posted three or more articles about the same Honig-backed company within a few days of one another. In many cases, they were the only writers posting stories about those stocks.
They routinely spotlighted companies backed by Honig and his associates. Zazoff was the official investor relations representative for some of the companies that were featured at Market Exclusive, or were touted on other sites by members of the stealth promotion network. Zazoff told Sharesleuth that although he established Market Exclusive, he sold the site to an investment group in 2013. That was before it began posting content on a regular basis.
He denied any involvement in the activities outlined in this report. Honig has helped dozens of small companies go public, primarily through reverse mergers with the shells of failed or failing businesses. He and his partners typically arrange the deals and provide financing, in return for significant amounts of stock or convertible notes. Although many of those companies have seen sharp, temporary increases in their stock prices, they seldom have produced long-term gains for ordinary investors. The Securities and Exchange Commission has been investigating Honig and his associates in connection with two other creations: MGT Capital Investments Inc. Both had sudden, promotion-fueled surges in their share prices and trading volume, which enabled Honig and members of his group to sell millions of dollars in stock. A third company brought public by Honig’s group — Mabvax Therapeutics Holdings Inc.
30 that the SEC was conducting an investigation related to its registration statements. They covered the resale of millions of shares issuable to Honig, Brauser, Frost, Opko and others, through the conversion of preferred stock. Mabvax was one of the stocks the stealth promotion network touted in 2016. Honig has always conducted his business dealings with the highest standards of ethics and integrity, and expects everyone he works with to do the same. The promotional articles and the methods employed are virtually identical to those at the heart of cases that the SEC brought last April against 27 individuals and entities, including three public companies and their chief executives. Our investigation turned up a certain amount of overlap between those schemes and the touting network covered in this report.
Some of the writers who were charged by the SEC last year wrote bullish articles about companies backed by Honig, Brauser and Frost, including Chromadex Corp. Those articles appeared in the period covered by the SEC actions. Similarly, some of the writers in the still-active touting network wrote favorable pieces about companies identified in the SEC cases. Those articles, too, appeared in the period covered by the SEC actions. It is legal for public companies, their investor relations consultants and other third parties to pay for touting campaigns and other promotional activities. Under SEC rules, however, writers or websites that get paid to provide favorable coverage must disclose that. They also are supposed to say how much money they received and who paid them.